Community Based Distribution, Contraception, DMPA, Family Planning, Task Shifting
Conditions
Keywords
Contraception, Family planning, Task Shifting, Community based distribution, Ethiopia, DMPA
Brief summary
The purpose of this study was to demonstrate that with appropriate training, the provision of injectable contraceptives by community based reproductive health agents (CBRHAs) does not significantly differ from low-level clinic-based providers, or health extension workers (HEWs).
Detailed description
The overall goal of this project was to increase contraceptive prevalence and reduce the current high unmet need for family planning in rural areas of Ethiopia. In addition, the project was intended to provide evidence to policy makers to expand community based distribution (CBD) of the injectible contraceptive, depot medroxyprogesterone acetate (DMPA), in both Tigray and other regions of Ethiopia where community based reproductive health agents (CBRHAs) or other community health workers (CHWs) are present. Following from that, the specific aims of this project were to: * Provide evidence that CBRHAs can safely and effectively distribute and facilitate supply of DMPA to rural women * Demonstrate that CBRHAs can deliver DMPA with the same safety, effectiveness, and acceptability outcomes as HEWs * Increase access to DMPA by using CBRHAs
Interventions
OTHERCommunity Based administration of DMPA
Injectable contraceptive administered by clinic based health extension worker or community based reproductive health agent using same protocol to test equivalence of community based distribution to facility based distribution
Sponsors
Tigray Regional Health Bureau
Venture Strategies for Health and Development
Venture Strategies innovations
University of California, Berkeley
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* All adult women of reproductive age who approached a provider for a contraceptive method and wished to use DMPA were recruited to participate in the study * Medically eligible to use injectable contraceptives
Exclusion criteria
* Health problems preventing or counter-indications for use of hormonal contraceptives * Suspicion of pregancy * FHI validated check list of eligibility use injectable contraceptives * Minors age \<18 years old
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Equivalence of injection administration | every 3 months | Injection site morbidities, induration etc |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Equivalent continuation rates | Every 3 months | Follow up injection rates at 2nd and 3rd injection. |
| Knowledge of side effects among clients | Every 3 months | The clients understand the efficacy, the drug usage, side effects and recourse for care if side effects manifest at 13 week and 6 month questionnaire |
Countries
Ethiopia
Outcome results
None listed